Medfield Diagnostics AB (publ)

NGM:MEDF Stok Raporu

Piyasa değeri: SEK 23.6m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Medfield Diagnostics Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Medfield Diagnostics has a total shareholder equity of SEK73.8M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK77.0M and SEK3.2M respectively.

Anahtar bilgiler

0%

Borç/özkaynak oranı

SEK 0

Borç

Faiz karşılama oranın/a
NakitSEK 7.11m
EşitlikSEK 73.77m
Toplam yükümlülüklerSEK 3.23m
Toplam varlıklarSEK 77.01m

Son finansal sağlık güncellemeleri

Recent updates

Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Deliver On Growth Plans?

May 12
Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Deliver On Growth Plans?

Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Invest In Growth?

Dec 29
Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Invest In Growth?

Companies Like Medfield Diagnostics (NGM:MEDF) Are In A Position To Invest In Growth

Sep 07
Companies Like Medfield Diagnostics (NGM:MEDF) Are In A Position To Invest In Growth

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: MEDF's short term assets (SEK11.9M) exceed its short term liabilities (SEK3.2M).

Uzun Vadeli Yükümlülükler: MEDF has no long term liabilities.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: MEDF is debt free.

Borcun Azaltılması: MEDF had no debt 5 years ago.


Bilanço


Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: MEDF has less than a year of cash runway based on its current free cash flow.

Tahmini Nakit Akışı: MEDF has less than a year of cash runway if free cash flow continues to reduce at historical rates of 9.9% each year


Sağlıklı şirketleri keşfedin